GLB Peptide MOG(35-55) (Mouse, Rat), CAS#149635-73-4

Myelin Oligodendrocyte Glycoprotein (35-55) (mouse, rat) 
MEVGWYRSPFSRVVHLYRNGK

Product	MOG(35-55)
Sequence	H-Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH
CAS#	149635-73-4
MDL#	MFCD06796003
Formula	C118H177N35O29S
M.W.	2581.95
Appearance	White to off-white lyophilised powder
Purity	≥90%, ≥95%, ≥98%
Solubility	H2O, PBS
Packaging	1mg, 5mg, 25mg, 100mg, 250mg, 1g... or pack on request
Storage	Kept under -20o or lower
Price	Request A Quote
Use	For the research and development purpose only
Cited in	Nam, et al., (2014). Lipocalin-2 Protein Deficiency Ameliorates Experimental Autoimmune Encephalomyelitis. J. Bio. Chem. 289, 16773-16789. Wang et al., (2014). Molecular Grafting onto a Stable Framework Yields Novel Cyclic Peptides for the Treatment of Multiple Sclerosis. ACS Chem. Bio. 9, 156-163. Zheng et al., (2014). T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis. Immunol. Lett. 157, 38–44. Payne, et al., (2013). Distinct Immunomodulatory and Migratory Mechanisms Underpin the Therapeutic Potential of Human Mesenchymal Stem Cells in Autoimmune Demyelination. Cell Transplantation 22, 1409-1425. Ko, et al., (2010). Transplantation of autoimmune regulator-encoding bone marrow cells delays the onset of experimental autoimmune encephalomyelitis. Eur. J. Immunol. 40, 3499-3509.